ARTL has been in the news 563% more than usual
Jul 07, 2025, 10:32 PM
17.61%
What does ARTL do
Artelo Biosciences, a clinical-stage biopharmaceutical company based in Solana Beach, California, focuses on developing therapeutics targeting lipid-signaling pathways and the endocannabinoid system. Its key programs include ART27.13 for anorexia and ART26.12 for cancer, pain, and anxiety.
ARTL has been in the news recently: ARTELO BIOSCIENCES reported a 15% increase in revenue this quarter, demonstrating strong demand for its products and effective market strategies. The growth was primarily driven by the success of its new product line and an expanded market presence.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.